臨床研究等提出・公開システム

Web-based questionnaire study to investigate patients' and physicians' perspectives regarding factors affecting patients' satisfaction and adherence to treatment, continuation/discontinuation of treatment, and clinical inertia in type 2 diabetes management

Web-based questionnaire study to investigate patients' and physicians' perspectives regarding factors affecting patients' satisfaction and adherence to treatment, continuation/discontinuation of treatment, and clinical inertia in type 2 diabetes management

1997

<Survey in physician> Age (years), mean: 49.5 Male (%): 90.1 Type of institution (%): University hospital, National public hospital and General hospital: 70.8, Clinic: 29.2 Type of medical department (%): Diabetes/Metabolism Endocrinology 40.9, General internal medicine/other: 59.1 Board Certified Diabetologist (%): 38.8 Average years of experience in the treatment of type 2 diabetes (years): 19.8 The number of patients with diabetes per month (median): 100 <Survey in patients> Age (years), mean: 63.8 Male (%): 73.9 Diabetes care is primarily received at (%): Hospital 40.5, Clinic 59.5 Type of medical department (%): Diabetes / Metabolic endocrinology 38.8, General internal medicine/other 61.2 Comorbidities (%): Hypertension 44.5, Dyslipidaemia 21.0, Obesity/Metabolic syndrome 12.9, Depressive disorder 6.3 Diabetic complications (%): Myocardial infarction 7.7, Stroke 2.3, Arteriosclerosis obliterans 1.9, Diabetic retinopathy 8.3, Diabetic neuropathy 7.7, Diabetic nephropathy 4.0

<Survey in physician> All respondents: 555 subjects Analysis population: 523 subjects <Survey in patients> All respondents: 1,442 subjects Analysis population: 1,203 subjects

None

<Survey in physician> Physicians answered the proportion of the patients with type2 diabetes who are satisfied with current diabetes treatment (%): Mostly dissatisfied: 7 Somewhat dissatisfied: 14 Neither satisfied nor dissatisfied: 27 Somewhat satisfied: 33 Mostly satisfied: 19 <Survey in patients> Physicians answered the proportion of the patients with type2 diabetes who take more than 80% of their antidiabetic drugs as specified (timing, number of times) (%): Mean (% [standard deviation]): 74.1(17.2) 0%: 0, 1-19%: 1, 20-39%: 4, 40-59%: 7, 60-79%: 33, 80-99%: 51, 100%: 4 <Survey in patients> Patients answered how satisfied you are with your current diabetes treatment (%): Mostly dissatisfied: 1 Somewhat dissatisfied: 7 Neither satisfied nor dissatisfied: 34 Somewhat satisfied: 44 Mostly satisfied: 14 Patients answered what percentage of the time you take your antidiabetic drugs as specified (timing, number of times) (%): 0%: 0, 1-19%: 0, 20-39%: 1, 40-59%: 2, 60-79%: 3, 80-99%: 34, 100%:60 Brief Summary: In this survey, 58% of patients answered that they were satisfied with current treatment, and physicians answered that 52% of their patients are satisfied with current treatment. However, treatment adherence in patients' response is numerically higher than patients' adherence of physicians' response.

- The number of discontinuation of diabetes treatment (%): More than 4 times: 10.3, 3 times: 7.4, 2 times: 10.8, 1 time: 26.1, none: 45.3 - Patient answered if you experience intensification of diabetes treatment (%): Yes: 51, No: 49

The analysis was based on the participants' self-assessment and is limited by the lack of objectivity and the potential for inaccuracies. There were gaps between physicians and patients in this survey, it is necessary to understand the gaps in the treatment of diabetes to maximize treatment outcome.

No

https://www.clinicaltrials.jp/file/DueGKPZYc

Takeda Pharmaceutical Company Limited

https://www.takeda.com/who-we-are/contact-us/

-

Takeda Pharmaceutical Company Limited

https://www.takeda.com/who-we-are/contact-us/

+81-6-6204-2111

-

completed

Mar. 06, 2019

Observational

A web-based questionnaire study

other

N/A

[Physician survey]
1.Medical experience in type 2 diabetes more than 3 years.
2.Treat more than 50 patients with type 2 diabetes per month

[Patient survey]
1.20 years old or older
2.Have type 2 diabetes
3.Not a healthcare provider

-

Both

Type 2 diabetes

investigational material(s)
Generic name etc : Not Applicable due to Web-based questionnaire study
INN of investigational material : -
Therapeutic category code : 396 Antidiabetic agents
Dosage and Administration for Investigational material : -

control material(s)
Generic name etc : -
INN of investigational material : -
Therapeutic category code :
Dosage and Administration for Investigational material : -

other
[Survey in physician]
Characteristics (Including screening item): 7 questions
[Survey in patient]
Characteristics (Including screening item): 20 questions

Timeframe: 12 days
other
[Survey in physician]
Measurement item: 24 questions
[Survey in patient]
Measurement item: 27 questions

Timeframe: 12 days

other
-

-

Mar. 04, 2019